Quirónsalud study flags haptoglobin, IgA2 blood markers as predictors of cardiovascular risk

• Grupo Hospitalario Quirón SA highlighted a new study linking two blood biomarkers to early, symptom-free atherosclerosis detection.
• Results have already been published in the Journal of the American Heart Association, dated Sept. 9, 2026.
• Elevated haptoglobin, immunoglobulin A2 levels were tied to higher odds of hidden plaque, improving risk identification beyond standard factors.
• Participants with higher levels of both markers faced a greater likelihood of future cardiovascular events, supporting potential prognostic use.
• Researchers framed the test as straightforward for hospitals, while calling for more studies before broad clinical adoption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grupo Hospitalario Quirón SA published the original content used to generate this news brief on September 11, 2026, and is solely responsible for the information contained therein.